Homologous Recombination Assay Kit
Rapid and sensitive tool for measuring the efficiency of homologous recombination
![Norgen Biotek Homologous Recombination Assay Kit](/sites/default/files/styles/norproduct_imagekit/public/PCR-mastermix_0.jpg?itok=XXiyssYg)
For research use only and NOT intended for in vitro diagnostics.
Homologous Recombination Assay Kit
Rapid and sensitive tool for measuring the efficiency of homologous recombination
Overview
- Rapid and sensitive tool for measuring the efficiency of homologous recombination
- For any cell types including prokaryotes and eukaryotes
- All primers included for quantification of the homologous recombination efficiency through qPCR.
Norgen’s Homologous Recombination Assay Kit provides a rapid and sensitive tool for measuring the efficiency of homologous recombination in both bacterial and mammalian cells. The kit consists of 5 components: (1) dl-1 plasmid, (2) dl-2 plasmid, (3) positive control plasmid, (4) assay primers mixture, and (5) universal primers mixture. The assay is based on the co-transformation of the two dl plasmids into bacterial cells followed by the isolation of plasmid DNA and quantification of the homologous recombination efficiency through qPCR. In addition, PCR can be used for qualitative analysis of the recombination efficiency. The primer mixture provided with the kit is designed to amplify only the homologous recombination product but not the dl plasmids (dl-1 or dl-2). The two plasmids can be co-transfected into mammalian cells, then the DNA can be isolated and the homologous recombination efficiency can be assayed by qPCR (or PCR). In addition, the efficiency of homologous recombination can be assessed in bacteria by blue/white screening using X-gal. The provided positive control contains the functional LacZ sequence and can be used as a positive control for the plasmid DNA isolation efficiency (after transformation or transfection) or PCRs. The use of PCR-based homologous recombination assay enhances the sensitivity and eliminates the need for labor intensive screening by using traditional protein expression and staining techniques and is suitable for high throughput screening studies. The kit is designed to perform 200 transformations or 24 transfections.
Details
Supporting Data
Figure 1. Schematic Representation of Homologous Recombination Assay. The lacZα coding region of the positive control plasmid was mutated and two plasmids with different mutations were generated. Therefore, the two plasmids containing different defective lacZα cassettes can form a functional lacZα cassette through intermolecular homologous recombination. The two defective plasmids, once transformed into bacterial cells, will form white colonies. Only the plasmid that has undergone homologous recombination and generated the functional lacZα can form blue colonies. The homologous recombination efficiencies can be determined by calculating the percentages of the blue colonies among all the blue and white colonies.
Figure 2: Real-time PCR Amplification of Plasmid DNA Isolated from HEK 293 Cells. Aftter transfection with the supplied plasmids genomic DNA was isolated from each well of a 6-well plate using Norgen’s RNA/DNA/Protein Purification Kit. Fifty nanograms of the positive control plasmid was transfected into each well of the HEK 293 cells, and the total DNA was isolated 12 h later. For the recombinant samples, 25 ng of dl-1 plus 25 ng of dl-2 were transfected and then isolated. For the negative controls, 50 ng of dl-1 or 50 ng of dl-2 were transfected and then isolated. The experiment was carried out in duplicate to avoid the reading error of the PCR machine.
Homologous Recombination Assay Kit Contents:
1. dl-1 Plasmid
2. dl-2 Plasmid
3. Positive Control Plasmid
4. Assay Primers Mixture
5. Universal Primers Mixture
6. Nuclease-Free Water
7. Product Insert
SHELF LIFE AND HANDLING
All solutions should be kept tightly sealed and stored at -20°C or lower temperature. This kit is stable for 5 years after the date of shipment.
Kit Component | Cat. 35600 (200 transformations/24 transfections) |
---|---|
dl-1 Plasmid | 12 μg (50 ng/μL) |
dl-2 Plasmid | 12 μg (50 ng/μL) |
Positive Control Plasmid | 5 μg (50 ng/μL) |
Assays Primers Mixture | 400 μL |
Universal Primers Mixture | 400 μL |
Nuclease-Free Water | 1.25 mL |
Product Insert | 1 |
Documentation
Citations
Title | Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition |
Journal | Science Signaling. 2024. |
Authors | Caroline Fidalgo Ribeiro, Silvia Rodrigues, Debora Campanella Bastos, Giuseppe Nicolò Fanelli, Hubert Pakula, Marco Foiani, Giorgia Zadra, Massimo Loda |
Title | Replicative Stress Coincides with Impaired Nuclear DNA Damage Response in COX4-1 Deficiency |
Journal | Int. J. Mol. Sci.. 2022. |
Authors | Liza Douiev , Chaya Miller, Guy Keller, Hadar Benyamini, Bassam Abu-Libdeh and Ann Saada |
Title | Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia. |
Journal | Clin Cancer Res. 2022. |
Authors | Maria R. Baer, Aksinija A. Kogan, Søren M. Bentzen, Tian Mi, Rena G. Lapidus, Vu H. Duong, Ashkan Emadi, Sandrine Niyongere, Casey L. O'Connell, Benjamin A. Youngblood, Stephen B. Baylin, Feyruz V. Rassool |
Title | Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers |
Journal | Am J Cancer Res. 2022. |
Authors | Arathi Rajan, Geetu R Varghese, Induprabha Yadev, Jaimie Anandan, Neetha R Latha, Dipyaman Patra, Neethu Krishnan, Krithiga Kuppusamy, Arathy V Warrier, Satej Bhushan, Revathy Nadhan, Ram Mohan Ram Kumar, and Priya Srinivas |
Title | Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51 |
Journal | Molecular Therapy. 2018. |
Authors | Eun Ju Lee, Injoo Hwang, Ji Yeon Lee, Jong Nam Park, Keun Cheon Kim, Gi-Hwam Kim, Chang-Mo Kang, Irene Kim, Seo-Yeon Lee, Hyo-Soo Kim |
Title | Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas |
Journal | Oncotarget. 2017. |
Authors | Muh-Lii Liang, Tsung-Han Hsieh, Yun-Ru Liu, Yi-Wei Chen, Yi-Yen Lee, Feng-Chi Chang, Shih-Chiej Lin, Ming-Chao Huang, Donald Ming-Tak Ho, Tai-Tong Wong, Yun Yen, and Muh-Hwa Yang |
Title | Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination |
Journal | Journal of Experimental & Clinical Research. 2017. |
Authors | Xin Zhang, Ran Xu, Chao Zhang, Yangyang Xu, Mingzhi Han, Bin Huang, Anjing Chen, Chen Qui, Frits Thorsenm Lars Prestegarden, Rolf Bjerkvig, Jian Wang and Xingang Li |
Title | 14-3-3sigma Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle via PARP1 and CHK2 |
Journal | Molecular Cancer Research. 2017. |
Authors | Chen Y, Li Z, Dong Z, Beebe J, Yang K, Fu L, Zhang JT. |
Title | Effect of endonuclease G depletion on plasmid DNA uptake and levels of homologous recombination in hela cells |
Journal | Molecular Cell Biology. 2016. |
Authors | V. Misic, M. El-Mogy, S. Geng, Y. Haj-Ahmad |
Title | Protein–Protein Interaction Inhibitors of BRCA1 Discovered Using Small Molecule Microarrays |
Journal | Small Molecule Microarrays. 2016. |
Authors | Na Z, Pan S, Uttamchandani M, Yao SQ. |
Title | Hypoxia Differentially Modulates the Genomic Stability of Clinical-Grade ADSCs and BM-MSCs in Long-Term Culture |
Journal | Stem Cells. 2015 |
Authors | Bigot N, Mouche A, Preti M, Loisel S, Renoud ML, Le Guével R, Sensebé L, Tarte K, Pedeux R |
Title | Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins. |
Journal | Molecular Cancer Research. 2015 |
Authors | Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A |
Title | Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. |
Journal | Cancer Research. 2014. |
Authors | Ohba S, Mukherjee J, See WL, Pieper RO. |